Conmed (CNMD) Interest Coverage Ratio (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -98.29% |
| Jun 30, 2025 | 4,640.34% |
| Mar 31, 2024 | 320.12% |
| Dec 31, 2023 | -154.82% |
| Sep 30, 2023 | 10.27% |
| Jun 30, 2023 | 121.48% |
| Mar 31, 2023 | 9,298.36% |
| Jun 30, 2022 | -95.14% |
| Mar 31, 2021 | 355.92% |
| Dec 31, 2020 | -130.81% |
| Sep 30, 2020 | 232.02% |
| Jun 30, 2020 | -235.70% |
| Mar 31, 2020 | -49.17% |
| Dec 31, 2019 | 44.18% |
| Sep 30, 2019 | -96.78% |
| Jun 30, 2019 | 1,847.98% |
| Sep 30, 2018 | -32.56% |
| Jun 30, 2018 | -8.63% |
| Mar 31, 2018 | 306.15% |
| Dec 31, 2017 | -162.07% |
| Sep 30, 2017 | -3.57% |
| Jun 30, 2017 | 580.04% |
| Mar 31, 2016 | 131.73% |
| Dec 31, 2015 | -129.52% |
| Sep 30, 2015 | 18.32% |
| Jun 30, 2015 | 11.14% |
| Mar 31, 2015 | -32.43% |
| Dec 31, 2014 | 598.25% |
| Sep 30, 2014 | -84.33% |
| Jun 30, 2014 | -14.35% |
| Mar 31, 2014 | 8.50% |
| Dec 31, 2013 | 71.37% |
| Sep 30, 2013 | -43.70% |
| Jun 30, 2013 | -2.59% |
| Mar 31, 2013 | -4.62% |
| Dec 31, 2012 | 16.07% |
| Sep 30, 2012 | -4.59% |
| Jun 30, 2012 | -7.15% |
| Mar 31, 2012 | 142.51% |
| Dec 31, 2011 | -391.91% |
| Sep 30, 2011 | -2.42% |
| Jun 30, 2011 | 2.28% |
| Mar 31, 2011 | 30.14% |
| Dec 31, 2010 | -15.45% |
| Sep 30, 2010 | 4.16% |